NCT04965649 2023-08-30
TIPHI
Centre Hospitalier Universitaire de NÄ«mes
Unknown
Clinical Trials
11 trialsNCT05787951 2023-03-28
Frequency and Risk Factors of Acute Myeloid Leukemia
Assiut University
Unknown
NCT03417427 2020-04-27
A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT03600558 2020-04-24
Efficacy of FLAG Regimen for the Treatment of Patients With AML
Tianjin Medical University General Hospital
Unknown
NCT03659084 2018-09-06
GREFFE
Hospices Civils de Lyon
Unknown
NCT02333838 2018-08-13
TBF-Cord
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT03114670 2017-06-14
Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT
Affiliated Hospital to Academy of Military Medical Sciences
Phase 1 Unknown
NCT01864902 2016-01-28
CART33
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02489929 2015-07-03
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
Assistance Publique Hopitaux De Marseille
Phase NA Unknown
NCT00111345 2012-05-23
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
University Hospital Muenster
Phase 2/3 Unknown
NCT01066338 2010-02-19
Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype
Samsung Medical Center
Unknown